Literature DB >> 11486119

Vasospasm in monkeys resolves because of loss of and encasement of subarachnoid blood clot.

Z D Zhang1, B Yamini, T Komuro, S Ono, L Johns, L S Marton, B Weir, R L Macdonald.   

Abstract

BACKGROUND AND
PURPOSE: We studied in monkeys why vasospasm resolves after subarachnoid hemorrhage (SAH).
METHODS: Monkeys underwent angiography and right (n=17) or bilateral (n=8) SAH. Animals with bilateral SAH underwent angiography 1, 3, 5, and 7 days later. Animals with right SAH underwent angiography 7 days later. The clot was then not removed (n=5), removed and replaced with fresh clot (n=7), or removed and not replaced (n=5). At the same time on day 7, the removed clot (n=12) or fresh clot (n=5) was placed on the left side. Angiography was repeated every 2 days until day 14.
RESULTS: SAH caused significant vasospasm on day 7 that resolved by day 14. Removal of clot on day 7 resulted in more rapid resolution of vasospasm. Placement of fresh clot onto arteries that had already been exposed to clot for 7 days produced vasospasm that persisted without resolving for an additional 7 days. Placement of 7-day-old clot from the right onto previously unexposed left arteries or of clot from blood removed from an animal 7 days after SAH caused significantly more rapid onset of vasospasm compared with de novo vasospasm. Microscopic examination of the clots showed they were surrounded by macrophages 7 days after SAH. Arterial compliance and contractility were reduced in relation to duration of the exposure of arteries to clot.
CONCLUSIONS: Vasospasm resolves because of loss of subarachnoid blood clot. We hypothesize that reduced spasmogen release from the clot contributes to resolution of vasospasm. There was no response in the cerebral arteries that rendered them less responsive to the subarachnoid clot.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11486119     DOI: 10.1161/01.str.32.8.1868

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Role of CT perfusion imaging in the diagnosis and treatment of vasospasm.

Authors:  Edward D Greenberg; Y Pierre Gobin; Howard Riina; Carl E Johnson; Apostolos J Tsiouris; Joseph Comunale; Pina C Sanelli
Journal:  Imaging Med       Date:  2011-06-01

Review 2.  Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.

Authors:  Jean G de Oliveira; Jürgen Beck; Christian Ulrich; Julian Rathert; Andreas Raabe; Volker Seifert
Journal:  Neurosurg Rev       Date:  2006-10-24       Impact factor: 3.042

Review 3.  Management of cerebral vasospasm.

Authors:  R Loch Macdonald
Journal:  Neurosurg Rev       Date:  2006-02-24       Impact factor: 3.042

4.  Controversies and evolving new mechanisms in subarachnoid hemorrhage.

Authors:  Sheng Chen; Hua Feng; Prativa Sherchan; Damon Klebe; Gang Zhao; Xiaochuan Sun; Jianmin Zhang; Jiping Tang; John H Zhang
Journal:  Prog Neurobiol       Date:  2013-09-25       Impact factor: 11.685

Review 5.  The importance of early brain injury after subarachnoid hemorrhage.

Authors:  Fatima A Sehba; Jack Hou; Ryszard M Pluta; John H Zhang
Journal:  Prog Neurobiol       Date:  2012-03-10       Impact factor: 11.685

6.  Lessons for the pathogenesis of vasospasm from a patient with sickle cell disease, moyamoya disease, subarachnoid hemorrhage, and 1 month of persistent vasospasm: illustrative case.

Authors:  William D Haselden; Patrick J Drew; Ephraim W Church
Journal:  J Neurosurg Case Lessons       Date:  2022-07-04

7.  Subarachnoid hemorrhage and the distribution of drugs delivered into the cerebrospinal fluid. Laboratory investigation.

Authors:  Ryszard M Pluta; John A Butman; Bawarjan Schatlo; Dennis L Johnson; Edward H Oldfield
Journal:  J Neurosurg       Date:  2009-11       Impact factor: 5.115

Review 8.  A Comparison of Pathophysiology in Humans and Rodent Models of Subarachnoid Hemorrhage.

Authors:  Jenna L Leclerc; Joshua M Garcia; Matthew A Diller; Anne-Marie Carpenter; Pradip K Kamat; Brian L Hoh; Sylvain Doré
Journal:  Front Mol Neurosci       Date:  2018-03-22       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.